FLUDARABİN-SİKLOFOSFAMİD (AZALTILMIŞ YOĞUNLUKLU)(RIC)

Kaynaklar:

1-Apperley J, Carreras E, Gluckman E, et al. 2012. "The EBMT-ESH Handbook: Haematopoietic Stem Cell Transplantation". Sixth Edition.

2-Auer, R. L., F. MacDougall, H. E. Oakervee, et al. 2012. "T-cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies." Br J Haematol 157(5):580-585

3-Bhurani, D., M. Schifter and I. Kerridge. 2008. "Folinic acid administration following MTX as prophylaxis for GVHD in allogeneic HSCT centres in Australia and New Zealand." Bone Marrow Transplant 42(8):547-550.

4-Khouri, I. F., M. Keating, M. Korbling, et al. 1998. "Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies." J Clin Oncol 16(8):2817-2824.

5-Khouri, I. F., R. M. Saliba, S. A. Giralt, et al. 2001. "Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality." Blood 98(13):3595-3599.

6-Wondergem, M. J., F. S. Dijkstra, O. J. Visser, et al. 2014. "Allogeneic transplantation after reduced-intensity conditioning with fludarabine-CY for both indolent and aggressive lymphoid malignancies." Bone Marrow Transplant 49(4):513-518.

7-Khouri, I. F., P. McLaughlin, R. M. Saliba, et al. 2008. "Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab." Blood 111(12):5530-5536.

8-Grigg, A. P., J. Gibson, P. G. Bardy, et al. 2007. "A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning." Biol Blood Marrow Transplant 13(5):560-567.

9-Nelson, R. P., Jr., M. Yu, J. E. Schwartz, et al. 2010. "Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia." Bone Marrow Transplant 45(8):1300-1308.

10-Davies, J. K., D. Taussig, H. Oakervee, et al. 2013. "Long-term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non-myeloablative conditioning without T cell depletion." Br J Haematol 162(4):525-529.

11-Khawaja, M. R., S. M. Perkins, J. E. Schwartz, et al. 2015. "Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia." Am J Hematol 90(2):97-99.